Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Natera Inc (NTRA)

Natera Inc (NTRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 29,536,740
  • Shares Outstanding, K 141,731
  • Annual Sales, $ 2,306 M
  • Annual Income, $ -208,160 K
  • EBIT $ -308 M
  • EBITDA $ -265 M
  • 60-Month Beta 1.68
  • Price/Sales 12.05
  • Price/Cash Flow N/A
  • Price/Book 15.84

Options Overview Details

View History
  • Implied Volatility 69.25% (-2.38%)
  • Historical Volatility 57.39%
  • IV Percentile 98%
  • IV Rank 90.95%
  • IV High 72.87% on 04/15/26
  • IV Low 32.92% on 06/16/25
  • Expected Move (DTE 25) 27.38 (13.14%)
  • Put/Call Vol Ratio 1.96
  • Today's Volume 899
  • Volume Avg (30-Day) 1,673
  • Put/Call OI Ratio 0.65
  • Today's Open Interest 28,387
  • Open Int (30-Day) 19,460
  • Expected Range 181.02 to 235.78

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.55
  • Number of Estimates 6
  • High Estimate $-0.41
  • Low Estimate $-0.65
  • Prior Year $-0.50
  • Growth Rate Est. (year over year) -10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
181.00 +15.14%
on 03/27/26
220.00 -5.27%
on 04/08/26
+10.02 (+5.05%)
since 03/17/26
3-Month
181.00 +15.14%
on 03/27/26
250.00 -16.64%
on 01/22/26
-22.85 (-9.88%)
since 01/16/26
52-Week
131.81 +58.11%
on 08/01/25
256.36 -18.71%
on 01/07/26
+60.32 (+40.73%)
since 04/17/25

Most Recent Stories

More News
3 Reasons We’re Fans of Natera (NTRA)

3 Reasons We’re Fans of Natera (NTRA)

NTRA : 208.40 (+6.27%)
Natera, UFP Technologies, Mettler-Toledo, and Viatris Shares Are Soaring, What You Need To Know

Natera, UFP Technologies, Mettler-Toledo, and Viatris Shares Are Soaring, What You Need To Know

NTRA : 208.40 (+6.27%)
UFPT : 202.38 (+4.30%)
VTRS : 14.68 (+4.78%)
MTD : 1,340.58 (+3.85%)
1 Cash-Producing Stock to Own for Decades and 2 That Underwhelm

1 Cash-Producing Stock to Own for Decades and 2 That Underwhelm

ITRI : 98.43 (+1.47%)
HLT : 341.03 (+3.22%)
NTRA : 208.40 (+6.27%)
Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics’ MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today highlighted Allogene Therapeutics’ (NASDAQ: ALLO) interim futility analysis from its registrational...

ALLO : 2.39 (+0.84%)
NTRA : 208.40 (+6.27%)
Judge Awards 30% Ongoing Royalty to Natera for its MRD-Related Patents

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today provided an update on a recent decision issued by the United States District Court in the District of...

NTRA : 208.40 (+6.27%)
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Find Risky

1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Find Risky

COMP : 8.14 (+11.51%)
NTRA : 208.40 (+6.27%)
SPT : 5.52 (-2.13%)
3 Reasons NTRA Has Explosive Upside Potential

3 Reasons NTRA Has Explosive Upside Potential

NTRA : 208.40 (+6.27%)
20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera’s Oncology Platform

Data from >75,000 patients underscore advances in AI-driven virtual genomics, Signatera™-guided treatment monitoring, and continued expansion of MRD and other capabilities

NTRA : 208.40 (+6.27%)
SignateraTM MRD Identifies Breast Cancer Patients Who Can Forgo Surgery

Prospective study published in Clinical Cancer Research shows that women >70 who tested Signatera MRD-negative could avoid surgery and remain progression-free

NTRA : 208.40 (+6.27%)
Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know

Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know

FTRE : 10.38 (+2.87%)
NTRA : 208.40 (+6.27%)
ELAN : 23.68 (+2.38%)
TNDM : 20.61 (+2.59%)
MYGN : 5.08 (+1.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.

See More

Key Turning Points

3rd Resistance Point 223.35
2nd Resistance Point 216.31
1st Resistance Point 212.36
Last Price 208.40
1st Support Level 201.36
2nd Support Level 194.32
3rd Support Level 190.37

See More

52-Week High 256.36
Fibonacci 61.8% 208.78
Last Price 208.40
Fibonacci 50% 194.09
Fibonacci 38.2% 179.39
52-Week Low 131.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.